A biotech company recently announced that it's implanted another pig kidney into a human recipient. Here's what to know.

A biotech company recently announced that it's implanted another pig kidney into a human recipient. Here's what to know. Jesse Orrall (he/him/his) is a Senior Video Producer for CNET. He covers ...

Colossal Biosciences Inc., a Dallas-based biotech firm with a $10 billion valuation, has announced a new breakthrough in its ...

Surgeons at NYU Langone Health in New York City had to remove a genetically modified pig kidney from Towana Looney, 53, of Gadsden, Ala., because her body rejected the organ. She's back on dialysis.

Both United Therapeutics Corp. which developed the kidney Looney received, and eGenesis, which developed the kidney transplanted in Boston, are launching studies to evaluate pig organs.

He likened Colossal to ARCH-baked eGenesis, the biotech company that has transplanted genetically engineered pig kidneys into humans. While eGenesis is targeted at a specific healthcare ...